Palomar Holdings, Inc. (NASDAQ:PLMR – Get Free Report) President Jon Christianson sold 1,991 shares of the stock in a transaction on Wednesday, January 28th. The shares were sold at an average price of $119.88, for a total value of $238,681.08. Following the completion of the transaction, the president directly owned 62,985 shares in the company, valued at approximately $7,550,641.80. This represents a 3.06% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.
Jon Christianson also recently made the following trade(s):
- On Tuesday, December 23rd, Jon Christianson sold 1,691 shares of Palomar stock. The stock was sold at an average price of $139.50, for a total value of $235,894.50.
- On Tuesday, November 18th, Jon Christianson sold 522 shares of Palomar stock. The shares were sold at an average price of $128.84, for a total value of $67,254.48.
Palomar Trading Up 0.3%
Shares of NASDAQ PLMR opened at $123.59 on Friday. The stock’s 50-day moving average is $127.65 and its 200 day moving average is $123.83. The stock has a market cap of $3.28 billion, a price-to-earnings ratio of 19.28 and a beta of 0.42. Palomar Holdings, Inc. has a 1-year low of $104.47 and a 1-year high of $175.85.
Institutional Inflows and Outflows
A number of hedge funds have recently added to or reduced their stakes in PLMR. Allworth Financial LP lifted its position in shares of Palomar by 1,970.0% in the 2nd quarter. Allworth Financial LP now owns 207 shares of the company’s stock worth $32,000 after purchasing an additional 197 shares during the period. Salomon & Ludwin LLC bought a new position in Palomar in the third quarter worth about $25,000. Richardson Financial Services Inc. lifted its holdings in Palomar by 210.0% in the third quarter. Richardson Financial Services Inc. now owns 217 shares of the company’s stock worth $25,000 after buying an additional 147 shares during the period. Geneos Wealth Management Inc. purchased a new stake in Palomar in the fourth quarter worth about $32,000. Finally, Hollencrest Capital Management boosted its position in Palomar by 56.5% during the 2nd quarter. Hollencrest Capital Management now owns 313 shares of the company’s stock valued at $48,000 after acquiring an additional 113 shares in the last quarter. 90.25% of the stock is owned by hedge funds and other institutional investors.
Trending Headlines about Palomar
Here are the key news stories impacting Palomar this week:
- Neutral Sentiment: Yahoo Finance published a piece asking whether PLMR’s recent price slide creates a long‑term buying opportunity — a constructive framing for value investors but speculative. Is Palomar Holdings (PLMR) Price Slide Creating A Long Term Opportunity For Investors
- Negative Sentiment: CEO Mac Armstrong sold 11,484 shares at $119.88 (≈$1.38M); his post-sale holding is 91,737 shares (11.13% decrease). SEC filing: CEO Sale Filing
- Negative Sentiment: President Jon Christianson sold 1,991 shares at $119.88 (≈$238.7k); post-sale holding 62,985 shares (3.06% decrease). SEC filing: President Sale Filing
- Negative Sentiment: CFO T. Christopher Uchida sold 2,103 shares at $119.88 (≈$252.1k); post-sale holding 11,473 shares (15.49% decrease). SEC filing: CFO Sale Filing
- Negative Sentiment: Insider Jonathan Knutzen sold 1,535 shares at $119.88 (≈$184.0k); post-sale holding 24,809 shares (5.83% decrease). SEC filing: Insider Sale Filing
- Negative Sentiment: Insider Angela L. Grant sold 1,447 shares at $119.88 (≈$173.5k); post-sale holding 5,242 shares (21.63% decrease). SEC filing: Insider Sale Filing
Analysts Set New Price Targets
A number of research analysts have recently issued reports on the company. JPMorgan Chase & Co. raised their price objective on Palomar from $145.00 to $155.00 and gave the company an “overweight” rating in a research note on Wednesday, January 7th. Weiss Ratings upgraded Palomar from a “hold (c+)” rating to a “buy (b-)” rating in a report on Wednesday, January 14th. Keefe, Bruyette & Woods lifted their price target on Palomar from $170.00 to $171.00 and gave the stock an “outperform” rating in a research note on Tuesday, January 6th. Finally, Wall Street Zen raised Palomar from a “hold” rating to a “buy” rating in a research note on Saturday, January 10th. Six research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $159.50.
Read Our Latest Analysis on Palomar
About Palomar
Palomar Holdings, Inc (NASDAQ: PLMR) is a specialty insurance holding company focused on providing medical stop-loss coverage and related administrative services to self-funded employer health plans in the United States. The firm operates through two primary business segments—Medical Stop-Loss and Specialty Program Management—to deliver tailored risk protection and comprehensive program administration.
In its Medical Stop-Loss segment, Palomar underwrites excess and aggregate stop-loss policies designed to shield self-insured employers from catastrophic medical claims that exceed pre-determined retention levels.
See Also
- Five stocks we like better than Palomar
- Stock market legend warns: “An Ominous Day Is Coming for the Markets…”
- Another reason you need to own gold… [running out]
- Trump’s Final Shocking Act Begins February 24
- NEW: Gold makes history
- Deutsche Bank Just Raised Their Gold Target to $6,000
Receive News & Ratings for Palomar Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Palomar and related companies with MarketBeat.com's FREE daily email newsletter.
